|
PPP1R8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.244300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.941600E-02 |
| Normal-vs-Stage2 |
1.721710E-02 |
| Normal-vs-Stage3 |
3.05869999994712E-06 |
| Normal-vs-Stage4 |
5.659800E-03 |
| Stage1-vs-Stage2 |
2.183400E-01 |
| Stage1-vs-Stage3 |
4.834300E-04 |
| Stage1-vs-Stage4 |
1.238970E-01 |
| Stage2-vs-Stage3 |
2.264000E-01 |
| Stage2-vs-Stage4 |
8.106400E-01 |
| Stage3-vs-Stage4 |
3.502000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.831300E-04 |
| Normal-vs-AfricanAmerican |
4.535700E-03 |
| Normal-vs-Asian |
8.081800E-01 |
| Caucasian-vs-AfricanAmerican |
3.951400E-01 |
| Caucasian-vs-Asian |
2.290600E-01 |
| AfricanAmerican-vs-Asian |
1.639240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.402620E-04 |
| Normal-vs-Female |
2.703600E-02 |
| Male-vs-Female |
7.619900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.087800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.895400E-03 |
| Normal-vs-Age(61-80Yrs) |
8.029500E-04 |
| Normal-vs-Age(81-100Yrs) |
8.553700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.949600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.698200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.154600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.180200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.613500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.650200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.414000E-01 |
| Normal-vs-Grade 2 |
3.253200E-01 |
| Normal-vs-Grade 3 |
9.55329999996479E-07 |
| Normal-vs-Grade 4 |
4.224200E-04 |
| Grade 1-vs-Grade 2 |
1.549410E-01 |
| Grade 1-vs-Grade 3 |
6.581300E-04 |
| Grade 1-vs-Grade 4 |
1.124610E-03 |
| Grade 2-vs-Grade 3 |
1.33829999970914E-07 |
| Grade 2-vs-Grade 4 |
1.683740E-03 |
| Grade 3-vs-Grade 4 |
8.349800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.179600E-01 |
| Normal-vs-ccB subtype |
2.20620000002114E-06 |
| ccA subtype-vs-ccB subtype |
4.47729999741853E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.403800E-04 |
| Normal-vs-N1 |
9.038200E-03 |
| N0-vs-N1 |
4.571000E-01 |
|
|
